PMN ProMIS Neurosciences, Inc.
Healthcare$10.98+1.67%ClosedMarket Cap: $14.4M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.18
P/S
0.00
EV/EBITDA
1.21
DCF Value
$0.00
FCF Yield
-247.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-238.0%
ROA
-60.3%
ROIC
-68.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-8.6M | $-8.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-10.8M | $-10.7M | $— | — |
| FY null | $0.00 | NaN% | $-40.2M | $-39.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-11.8M | $-11.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-10.2M | $-10.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-7.5M | $-7.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-6.0M | $-238.2K | $— | — |
| FY null | $0.00 | NaN% | $-16.8M | $2.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.4M | $9.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.7M | $-2.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.7M | $-3.6M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-3.9M | $-3.6M | $-4.75 | — |